Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 6 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Roivant Sciences Ltd have a median target of 16.50, with a high estimate of 22.00 and a low estimate of 12.50. The median estimate represents a 39.59% increase from the last price of 11.82.
High | 86.1% | 22.00 |
Med | 39.6% | 16.50 |
Low | 5.8% | 12.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 11, 2025.
Average growth rate | -25.40% |
More ▼
Revenue history & estimates in USD
Average growth rate | +5.41% |
Average growth rate | +57.24% |
More ▼